CD8A and pneumocystosis: Our data suggest that many laboratory indicators, such as CD3+, CD4+, CD8+ T cell numbers and LDH, can serve as risk factors for PJP occurrence, and a model based on combination of CD8+ T cell number and LDH shows prominent value for predicting the development of PJP in HIV-negative patients undergoing immunosuppressive therapy.